$GNSS
Genasys Inc. Stock $gnss

$gnss Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000143774921027262 Filed on November 23, 2021

Income Statement

Concept	2021 Q4	2021 Q3	2021
Revenue	$10.68M	$15.05M	$47.00M
YoY Change	33.0%	7.63%	9.28%
Cost Of Revenue	$5.783M	$7.348M	$23.58M
YoY Change	33.74%	14.45%	15.74%
Gross Profit	$4.894M	$7.699M	$23.43M
YoY Change	32.13%	1.84%	3.48%
Gross Profit Margin	45.84%	51.17%	49.84%
Selling, General & Admin	$5.134M	$5.453M	$17.42M
YoY Change	54.13%	72.56%	44.67%
% of Gross Profit	104.9%	70.83%	74.38%
Research & Development	$1.369M	$1.502M	$4.918M
YoY Change	28.42%	13.79%	7.99%
% of Gross Profit	27.97%	19.51%	20.99%
Depreciation & Amortization	$639.0K	$644.0K	$1.597M
YoY Change	127.4%	257.78%	99.63%
% of Gross Profit	13.06%	8.36%	6.82%
Operating Expenses	$6.503M	$6.955M	$22.34M
YoY Change	47.9%	54.9%	34.61%
Operating Profit	-$1.609M	$744.0K	$1.084M
YoY Change	132.18%	-75.77%	-82.06%
Interest Expense		$76.00K	$76.00K
YoY Change		-5.0%	-5.0%
% of Operating Profit		10.22%	7.01%
Other Income/Expense, Net	$13.00K	-$81.00K	$54.00K
YoY Change	-81.16%	-46.0%	-57.48%
Pretax Income	-$1.596M	$699.0K	$1.138M
YoY Change	155.77%	-76.7%	-81.55%
Income Tax	-$291.0K	-$72.00K	$434.0K
% Of Pretax Income		-10.3%	38.14%
Net Earnings	-$1.305M	$771.0K	$704.0K
YoY Change	110.82%	-91.84%	-94.07%
Net Earnings / Revenue	-12.22%	5.12%	1.5%
Basic Earnings Per Share	-$0.04		$0.02
Diluted Earnings Per Share	-$0.04	$18.82K	$0.02
COMMON SHARES
Basic Shares Outstanding	36.48M	36.14M	34.41M
Diluted Shares Outstanding	36.46M		35.59M

Balance Sheet

Concept	2021 Q4	2021 Q3	2021
SHORT-TERM ASSETS
Cash & Short-Term Investments	$13.17M	$13.17M	$18.85M
YoY Change	-47.54%	-52.26%	-31.64%
Cash & Equivalents	$13.17M	$13.17M	$13.17M
Short-Term Investments	$0.00	$0.00	$5.686M
Other Short-Term Assets	$127.0K	$315.0K	$2.534M
YoY Change	-44.3%	9.38%	122.28%
Inventory	$9.142M	$6.416M	$6.416M
Prepaid Expenses
Receivables	$6.787M	$7.682M	$7.682M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$31.50M	$35.49M	$35.49M
YoY Change	-13.06%	-11.55%	-11.55%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.821M	$1.755M	$6.617M
YoY Change	-3.4%	-9.07%	-8.35%
Goodwill	$23.79M	$23.83M
YoY Change	179.85%	864.16%
Intangibles	$12.25M	$12.80M
YoY Change	227.3%	1257.79%
Long-Term Investments	$3.381M	$1.875M	$1.875M
YoY Change	39.71%	-50.79%	-50.79%
Other Assets	$9.852M	$9.513M	$9.513M
YoY Change	-20.8%	-18.13%	-18.13%
Total Long-Term Assets	$55.78M	$54.64M	$54.64M
YoY Change	62.29%	109.76%	109.76%
TOTAL ASSETS
Total Short-Term Assets	$31.50M	$35.49M	$35.49M
Total Long-Term Assets	$55.78M	$54.64M	$54.64M
Total Assets	$87.28M	$90.13M	$90.13M
YoY Change	23.62%	36.21%	36.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.259M	$2.160M	$2.160M
YoY Change	39.62%	57.66%	57.66%
Accrued Expenses	$12.61M	$14.11M	$5.187M
YoY Change	60.69%	79.07%	22.33%
Deferred Revenue	$9.666M	$9.821M
YoY Change	75.3%	122.5%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$290.0K	$296.0K	$296.0K
YoY Change	-7.64%	-1.33%	-1.33%
Total Short-Term Liabilities	$16.07M	$17.47M	$17.47M
YoY Change	51.17%	69.23%	69.24%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
Other Long-Term Liabilities	$995.0K	$995.0K	$6.704M
YoY Change	8.74%	239.59%	0.21%
Total Long-Term Liabilities	$995.0K	$995.0K	$6.704M
YoY Change	6.65%	219.94%	-0.09%
TOTAL LIABILITIES
Total Short-Term Liabilities	$16.07M	$17.47M	$17.47M
Total Long-Term Liabilities	$995.0K	$995.0K	$6.704M
Total Liabilities	$22.55M	$24.17M	$24.17M
YoY Change	25.65%	41.95%	41.93%
SHAREHOLDERS EQUITY
Retained Earnings	-$42.46M	-$41.15M
YoY Change	-0.04%	-1.68%
Common Stock	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$64.73M	$65.96M	$65.96M
YoY Change
Total Liabilities & Shareholders Equity	$87.28M	$90.13M	$90.13M
YoY Change	23.62%	36.21%	36.21%

Cashflow Statement

Concept	2021 Q4	2021 Q3	2021
OPERATING ACTIVITIES
Net Income	-$1.305M	$771.0K	$704.0K
YoY Change	110.82%	-91.84%	-94.07%
Depreciation, Depletion And Amortization	$639.0K	$644.0K	$1.597M
YoY Change	127.4%	257.78%	99.63%
Cash From Operating Activities	-$2.702M	-$2.164M	$6.150M
YoY Change	-312.42%	-167.41%	-11.1%
INVESTING ACTIVITIES
Capital Expenditures	$159.0K	-$27.00K	$208.0K
YoY Change	448.28%	-10.0%	48.57%
Acquisitions	$0.00		$15.85M
YoY Change	-100.0%
Other Investing Activities	$231.0K	$710.0K	-$15.35M
YoY Change	-105.45%	-202.9%	411.53%
Cash From Investing Activities	$72.00K	$683.0K	-$15.55M
YoY Change	-101.69%	-196.2%	396.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$441.0K		$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net	$0.00		$19.00K
YoY Change
Cash From Financing Activities	-$395.0K	40.00K	$13.00K
YoY Change	-831.48%	-71.43%	-98.09%
NET CHANGE
Cash From Operating Activities	-$2.702M	-2.164M	$6.150M
Cash From Investing Activities	$72.00K	683.0K	-$15.55M
Cash From Financing Activities	-$395.0K	40.00K	$13.00K
Net Change In Cash	-$3.036M	-1.441M	-$9.468M
YoY Change	3.37%	-154.58%	-311.39%
FREE CASH FLOW
Cash From Operating Activities	-$2.702M	-$2.164M	$6.150M
Capital Expenditures	$159.0K	-$27.00K	$208.0K
Free Cash Flow	-$2.861M	-$2.137M	$5.942M
YoY Change	-330.17%	-165.96%	-12.33%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	36482197
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2020Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2020Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2021Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2020Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2021Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2020Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2020Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2020Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	36403833
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36403833
CY2020Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33561544
CY2020Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33561544
CY2021	gnss	Investments Typical Final Maturity InvestmentsTypicalFinalMaturity	P3Y
CY2020Q3	gnss	Deferred Revenue For Collection Issues DeferredRevenueForCollectionIssues	0	USD
CY2021Q3	gnss	Deferred Revenue For Collection Issues DeferredRevenueForCollectionIssues	0	USD
CY2020	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
CY2020Q3	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	USD
CY2021Q3	us-gaap	Marketable Securities MarketableSecurities	0	USD
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2021Q3	us-gaap	Capitalized Contract Cost Amortization Period CapitalizedContractCostAmortizationPeriod	P4Y
CY2020	us-gaap	Short Term Lease Cost ShortTermLeaseCost	0	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2021Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	8313000	USD
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P7Y
CY2021	us-gaap	Dividends Dividends	0	USD
CY2020	us-gaap	Dividends Dividends	0	USD
CY2020Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13167000	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23319000	USD
CY2021Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	5686000	USD
CY2020Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	4265000	USD
CY2021Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	279000	USD
CY2020Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	282000	USD
CY2021Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7682000	USD
CY2020Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5442000	USD
CY2021Q3	us-gaap	Inventory Net InventoryNet	6416000	USD
CY2020Q3	us-gaap	Inventory Net InventoryNet	5949000	USD
CY2021Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2255000	USD
CY2020Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	860000	USD
CY2021Q3	us-gaap	Assets Current AssetsCurrent	35485000	USD
CY2020Q3	us-gaap	Assets Current AssetsCurrent	40117000	USD
CY2021Q3	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	1875000	USD
CY2020Q3	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	3805000	USD
CY2021Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1082000	USD
CY2020Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	395000	USD
CY2021Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	8039000	USD
CY2020Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	11095000	USD
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1755000	USD
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1930000	USD
CY2021Q3	us-gaap	Goodwill Goodwill	23834000	USD
CY2020Q3	us-gaap	Goodwill Goodwill	2472000	USD
CY2021Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	12804000	USD
CY2020Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	943000	USD
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4862000	USD
CY2020Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5285000	USD
CY2021Q3	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	392000	USD
CY2020Q3	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	125000	USD
CY2021Q3	us-gaap	Assets Assets	90128000	USD
CY2020Q3	us-gaap	Assets Assets	66167000	USD
CY2021Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2160000	USD
CY2020Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1370000	USD
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	14111000	USD
CY2020Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7880000	USD
CY2021Q3	us-gaap	Notes Payable Current NotesPayableCurrent	296000	USD
CY2020Q3	us-gaap	Notes Payable Current NotesPayableCurrent	300000	USD
CY2021Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	899000	USD
CY2020Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	771000	USD
CY2021Q3	us-gaap	Liabilities Current LiabilitiesCurrent	17466000	USD
CY2020Q3	us-gaap	Liabilities Current LiabilitiesCurrent	10321000	USD
CY2021Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	0	USD
CY2020Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	18000	USD
CY2021Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	995000	USD
CY2020Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	293000	USD
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5709000	USD
CY2020Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6395000	USD
CY2021Q3	us-gaap	Liabilities Liabilities	24170000	USD
CY2020Q3	us-gaap	Liabilities Liabilities	17027000	USD
CY2021Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	0	USD
CY2020Q3	us-gaap	Common Stock Value CommonStockValue	0	USD
CY2021Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	107110000	USD
CY2020Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	91248000	USD
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-41154000	USD
CY2020Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-41858000	USD
CY2021Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2000	USD
CY2020Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-250000	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	65958000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	49140000	USD
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	90128000	USD
CY2020Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	66167000	USD
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	47003000	USD
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	43010000	USD
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	23577000	USD
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	20371000	USD
CY2021	us-gaap	Gross Profit GrossProfit	23426000	USD
CY2020	us-gaap	Gross Profit GrossProfit	22639000	USD
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	17424000	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	12044000	USD
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4918000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4554000	USD
CY2021	us-gaap	Operating Expenses OperatingExpenses	22342000	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	16598000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	1084000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	6041000	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	54000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	127000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1138000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	6168000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	434000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-5706000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	704000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	11874000	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.36
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	35381000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	980000	USD
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1136000	USD
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.35
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34409478
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33220915
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	35589148
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34092328
CY2021	us-gaap	Net Income Loss NetIncomeLoss	704000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	11874000	USD
CY2021	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-8000	USD
CY2020	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-4000	USD
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	260000	USD
CY2020	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	213000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	956000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	12083000	USD
CY2020	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
CY2020	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	42000	USD
CY2020	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	398000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	209000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	11874000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	49140000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1424000	USD
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	210000	USD
CY2021	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
CY2021	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	141000	USD
CY2021	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	10938000	USD
CY2021	gnss	Adjustments To Additional Paid In Capital Stock Obligation To Issue Acquisition AdjustmentsToAdditionalPaidInCapitalStockObligationToIssueAcquisition	3431000	USD
CY2021	gnss	Stock Released From Obligation To Issue Value StockReleasedFromObligationToIssueValue	0	USD
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	252000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	704000	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	65958000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	704000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	11874000	USD
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1597000	USD
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	800000	USD
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	11000	USD
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	USD
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	4000	USD
CY2021	gnss	Product Warranty Expense Benefit ProductWarrantyExpenseBenefit	54000	USD
CY2020	gnss	Product Warranty Expense Benefit ProductWarrantyExpenseBenefit	16000	USD
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	379000	USD
CY2020	us-gaap	Inventory Write Down InventoryWriteDown	407000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	1424000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	980000	USD
CY2021	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	76000	USD
CY2020	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-0	USD
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-0	USD
CY2020	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-76000	USD
CY2021	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	433000	USD
CY2020	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-5708000	USD
CY2021	gnss	Operating Lease Rightofuse Asset Amortization Expense OperatingLeaseRightofuseAssetAmortizationExpense	694000	USD
CY2020	gnss	Operating Lease Rightofuse Asset Amortization Expense OperatingLeaseRightofuseAssetAmortizationExpense	599000	USD
CY2021	us-gaap	Accretion Expense AccretionExpense	46000	USD
CY2020	us-gaap	Accretion Expense AccretionExpense	0	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2138000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1775000	USD
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	846000	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	521000	USD
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	1634000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-927000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	600000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	477000	USD
CY2021	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	4902000	USD
CY2020	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-1238000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6150000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6918000	USD
CY2021	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	5144000	USD
CY2020	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	8056000	USD
CY2021	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	5646000	USD
CY2020	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	5061000	USD
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	15848000	USD
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-0	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	208000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	140000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-15554000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3135000	USD
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	210000	USD
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1136000	USD
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	-0	USD
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	398000	USD
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	141000	USD
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	42000	USD
CY2021	us-gaap	Repayments Of Unsecured Debt RepaymentsOfUnsecuredDebt	18000	USD
CY2020	us-gaap	Repayments Of Unsecured Debt RepaymentsOfUnsecuredDebt	17000	USD
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	38000	USD
CY2020	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	-0	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	13000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	679000	USD
CY2021	us-gaap	Effect Of Exchange Rate On Cash EffectOfExchangeRateOnCash	-77000	USD
CY2020	us-gaap	Effect Of Exchange Rate On Cash EffectOfExchangeRateOnCash	17000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-9468000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4479000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	23996000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	19517000	USD
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	14528000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	23996000	USD
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13167000	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23319000	USD
CY2021Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	279000	USD
CY2020Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	282000	USD
CY2021Q3	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1082000	USD
CY2020Q3	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	395000	USD
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	14528000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	23996000	USD
CY2021	gnss	Noncash Or Part Noncash Unrealized Loss On Marketable Securities NoncashOrPartNoncashUnrealizedLossOnMarketableSecurities	-7000	USD
CY2020	gnss	Noncash Or Part Noncash Unrealized Loss On Marketable Securities NoncashOrPartNoncashUnrealizedLossOnMarketableSecurities	-4000	USD
CY2021	gnss	Initial Measurement Of Operating Lease Right Of Use Assets InitialMeasurementOfOperatingLeaseRightOfUseAssets	259000	USD
CY2020	gnss	Initial Measurement Of Operating Lease Right Of Use Assets InitialMeasurementOfOperatingLeaseRightOfUseAssets	5824000	USD
CY2021	gnss	Initial Measurement Of Operating Lease Liabilities InitialMeasurementOfOperatingLeaseLiabilities	259000	USD
CY2020	gnss	Initial Measurement Of Operating Lease Liabilities InitialMeasurementOfOperatingLeaseLiabilities	7815000	USD
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	30980000	USD
CY2020	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	0	USD
CY2021	us-gaap	Nature Of Operations NatureOfOperations	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">1.</em> OPERATIONS </b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:25pt;">Genasys Inc. is a global provider of critical communications hardware and software solutions designed to alert, inform, and protect. The Company's unified platform receives information from a wide variety of sensors and Internet-of-Things (IoT) inputs to collect real-time information on developing and active emergency situations. The Company uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channels before, during, and after public safety and enterprise threats, critical events, and other crisis situations.</p>
CY2021Q3	gnss	Number Of Additional Inactive Subsidiaries NumberOfAdditionalInactiveSubsidiaries	2	pure
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"/> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>USE OF ESTIMATES </b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:25pt;">The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions (e.g., share-based compensation valuation, allowance for doubtful accounts, valuation of inventory and intangible assets, warranty reserve, accrued bonus and valuation allowance related to deferred tax assets) that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the financial statements and affect the reported amounts of revenues and expenses during the reporting periods. Actual results could materially differ from those estimates.</p>
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"/> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>CONCENTRATION OF CREDIT RISK </b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:25pt;">The Company sells its products to a large number of geographically diverse customers. The Company routinely assesses the financial strength of its customers. It is customary for the Company to require a deposit as collateral. As of <em style="font: inherit;"> September </em><em style="font: inherit;">30,</em> <em style="font: inherit;">2021,</em> accounts receivable from two customers accounted for 66% and 18% of total accounts receivable with <em style="font: inherit;">no</em> other single customer accounting for more than <em style="font: inherit;">10%</em> of the accounts receivable balance. As of <em style="font: inherit;"> September </em><em style="font: inherit;">30,</em> <em style="font: inherit;">2020,</em> accounts receivable from two customers accounted for 36% and 24% of total accounts receivable with <em style="font: inherit;">no</em> other single customer accounting for more than <em style="font: inherit;">10%</em> of the accounts receivable balance.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:25pt;">The Company maintains cash and cash equivalent bank deposit accounts which, at times, <em style="font: inherit;"> may </em>exceed federally insured limits guaranteed by the Federal Deposit Insurance Corporation (“FDIC”). The Company has <em style="font: inherit;">not</em> experienced any losses in such accounts. The Company limits its exposure to credit loss by depositing its cash with high credit quality financial institutions. The Company also invests cash in instruments that meet high credit quality standards, as specified in the Company’s policy guidelines such as money market funds, corporate bonds, municipal bonds and Certificates of Deposit. These guidelines also limit the amount of credit exposure to any <em style="font: inherit;">one</em> issue, issuer or type of instrument. It is generally the Company’s policy to invest in instruments that have a final maturity of <em style="font: inherit;">no</em> longer than <span style="-sec-ix-hidden:c79542772">three</span> years, with a portfolio weighted average maturity of <em style="font: inherit;">no</em> longer than 18 months.</p>
CY2021	gnss	Investments Typical Portfolio Weighted Average Maturity InvestmentsTypicalPortfolioWeightedAverageMaturity	P18M
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13167000	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23319000	USD
CY2021Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1361000	USD
CY2020Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	677000	USD
CY2021Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	127000	USD
CY2020Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	130000	USD
CY2021	gnss	Inventory Obsolescence Write Down Recoveries InventoryObsolescenceWriteDownRecoveries	-183000	USD
CY2020	gnss	Inventory Obsolescence Write Down Recoveries InventoryObsolescenceWriteDownRecoveries	-37000	USD
CY2021	us-gaap	Advertising Expense AdvertisingExpense	193000	USD
CY2020	us-gaap	Advertising Expense AdvertisingExpense	263000	USD
CY2021Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	146000	USD
CY2020Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	126000	USD
CY2021	us-gaap	Property Plant And Equipment Impairment PropertyPlantAndEquipmentImpairment	<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"/><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"/> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>IMPAIRMENT OF LONG-LIVED ASSETS </b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:25pt;">Long-lived assets and finite-lived intangibles held for use are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount <em style="font: inherit;"> may </em><em style="font: inherit;">not</em> be recoverable. If the carrying value of an intangible asset exceeds the fair value, or if changes in facts and circumstances indicate impairment, an impairment loss is measured and recognized using the asset’s fair value. There was <span style="-sec-ix-hidden:c79542859"><span style="-sec-ix-hidden:c79542860">no</span></span> impairment of long-lived assets for the years ended <em style="font: inherit;"> September 30, 2021 </em>and <em style="font: inherit;"> September 30, 2020. </em>Refer to Note <em style="font: inherit;">6,</em> Fair Value Measurements and Note <em style="font: inherit;">9,</em> Goodwill and Intangible Assets for information related to impairment of long-lived assets.</p>
CY2020	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
CY2020	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	pure
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	260000	USD
CY2021	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"/> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>RECLASSIFICATIONS </b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:25pt;">Where necessary, the prior year’s information has been reclassified to conform to the fiscal year <em style="font: inherit;">2021</em> statement presentation. These reclassifications had <em style="font: inherit;">no</em> effect on previously reported results of operations or accumulated deficit.</p>
CY2021Q2	us-gaap	Share Price SharePrice	5.05
CY2020Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables	120000	USD
CY2020Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets	106000	USD
CY2020Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable	194000	USD
CY2020Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities	2729000	USD
CY2020Q4	us-gaap	Share Price SharePrice	5.98
CY2021Q3	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	USD
CY2020Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4707000	USD
CY2021	gnss	Contract With Customer Liability Increase For New Contract ContractWithCustomerLiabilityIncreaseForNewContract	17410000	USD
CY2021	gnss	Contract With Customer Liability Revenue Recognized During Period ContractWithCustomerLiabilityRevenueRecognizedDuringPeriod	11996000	USD
CY2021	gnss	Contract With Customer Liability Effect Of Exchange Rate ContractWithCustomerLiabilityEffectOfExchangeRate	-8000	USD
CY2021Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	10129000	USD
CY2021Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	308000	USD
CY2021Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	9821000	USD
CY2021Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	10129000	USD
CY2021Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	9821000	USD
CY2021Q3	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.97	pure
CY2021Q3	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2021Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	5449000	USD
CY2020Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	5220000	USD
CY2021Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	842000	USD
CY2020Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	841000	USD
CY2021Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	877000	USD
CY2020Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	456000	USD
CY2021Q3	us-gaap	Inventory Gross InventoryGross	7168000	USD
CY2020Q3	us-gaap	Inventory Gross InventoryGross	6517000	USD
CY2021Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	752000	USD
CY2020Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	568000	USD
CY2021Q3	us-gaap	Inventory Net InventoryNet	6416000	USD
CY2020Q3	us-gaap	Inventory Net InventoryNet	5949000	USD
CY2021Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4685000	USD
CY2021Q3	us-gaap	Other Assets Current OtherAssetsCurrent	315000	USD
CY2020Q3	us-gaap	Other Assets Current OtherAssetsCurrent	288000	USD
CY2020Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4429000	USD
CY2021Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2930000	USD
CY2020Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2499000	USD
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1755000	USD
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1930000	USD
CY2021	us-gaap	Depreciation Depreciation	406000	USD
CY2020	us-gaap	Depreciation Depreciation	498000	USD
CY2021Q3	us-gaap	Goodwill Goodwill	23834000	USD
CY2020Q3	us-gaap	Goodwill Goodwill	2472000	USD
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2020Q3	us-gaap	Goodwill Goodwill	2472000	USD
CY2021	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	21128000	USD
CY2021	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	234000	USD
CY2021Q3	us-gaap	Goodwill Goodwill	23834000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	14861000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1829000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2057000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	886000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	12804000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	943000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	943000	USD
CY2021	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	12920000	USD
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1191000	USD
CY2021	us-gaap	Finite Lived Intangible Assets Foreign Currency Translation Gain Loss FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss	132000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	12804000	USD
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1191000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	302000	USD
CY2021Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2255000	USD
CY2020Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	860000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2169000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2137000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2123000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1995000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1855000	USD
CY2021Q3	gnss	Finitelived Intangible Asset Expected Amortization After Year Four FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour	2525000	USD
CY2021Q3	gnss	Finite Lived Intangible Assets Amortization Expense Total FiniteLivedIntangibleAssetsAmortizationExpenseTotal	12804000	USD
CY2021Q3	gnss	Deposits For Inventory DepositsForInventory	997000	USD
CY2020Q3	gnss	Deposits For Inventory DepositsForInventory	54000	USD
CY2021Q3	us-gaap	Prepaid Insurance PrepaidInsurance	395000	USD
CY2020Q3	us-gaap	Prepaid Insurance PrepaidInsurance	264000	USD
CY2021Q3	gnss	Due And Subscription DueAndSubscription	213000	USD
CY2020Q3	gnss	Due And Subscription DueAndSubscription	151000	USD
CY2021Q3	gnss	Prepaid Professional Services PrepaidProfessionalServices	158000	USD
CY2020Q3	gnss	Prepaid Professional Services PrepaidProfessionalServices	0	USD
CY2021Q3	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	82000	USD
CY2020Q3	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	0	USD
CY2021Q3	gnss	Prepaid Trade Shows And Travel PrepaidTradeShowsAndTravel	95000	USD
CY2020Q3	gnss	Prepaid Trade Shows And Travel PrepaidTradeShowsAndTravel	103000	USD
CY2021Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3726000	USD
CY2020Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2545000	USD
CY2021Q3	gnss	Accrued Contract Costs AccruedContractCosts	416000	USD
CY2020Q3	gnss	Accrued Contract Costs AccruedContractCosts	719000	USD
CY2021Q3	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	146000	USD
CY2020Q3	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	126000	USD
CY2021Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2000	USD
CY2020Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	76000	USD
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	14111000	USD
CY2020Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7880000	USD
CY2021Q3	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	687000	USD
CY2020Q3	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	0	USD
CY2021Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	995000	USD
CY2020Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	293000	USD
CY2020Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	126000	USD
CY2019Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	150000	USD
CY2021	gnss	Product Warranty Accrual Increase Decrease For New Warranties Issuance And Adjustment Preexisting Warranties ProductWarrantyAccrualIncreaseDecreaseForNewWarrantiesIssuanceAndAdjustmentPreexistingWarranties	56000	USD
CY2020	gnss	Product Warranty Accrual Increase Decrease For New Warranties Issuance And Adjustment Preexisting Warranties ProductWarrantyAccrualIncreaseDecreaseForNewWarrantiesIssuanceAndAdjustmentPreexistingWarranties	16000	USD
CY2021	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	36000	USD
CY2020	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	40000	USD
CY2021Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	146000	USD
CY2020Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	126000	USD
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	19000	USD
CY2021	gnss	Longterm Debt Currency Translation LongtermDebtCurrencyTranslation	3000	USD
CY2021Q3	us-gaap	Long Term Debt LongTermDebt	296000	USD
CY2020Q3	us-gaap	Long Term Debt LongTermDebt	318000	USD
CY2021Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths	296000	USD
CY2021Q3	us-gaap	Long Term Debt LongTermDebt	296000	USD
CY2021	gnss	Increase In Lease Liability With10 Increase In Index IncreaseInLeaseLiabilityWith10IncreaseInIndex	19000	USD
CY2020Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5285000	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	259000	USD
CY2021	gnss	Operating Lease Rightofuse Asset Amortization Expense OperatingLeaseRightofuseAssetAmortizationExpense	694000	USD
CY2021	gnss	Effect Of Exchange Rate On Operating Lease Rou Assets EffectOfExchangeRateOnOperatingLeaseROUAssets	12000	USD
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4862000	USD
CY2020Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	7166000	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	259000	USD
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	829000	USD
CY2021	gnss	Effect Of Exchange Rate On Operating Lease Liability EffectOfExchangeRateOnOperatingLeaseLiability	12000	USD
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	6608000	USD
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5709000	USD
CY2021Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	899000	USD
CY2021Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y8M12D
CY2021Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.041	pure
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1151000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1089000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1084000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1057000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1069000	USD
CY2021Q3	gnss	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	2139000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	7589000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	981000	USD
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	6608000	USD
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	991000	USD
CY2020	us-gaap	Operating Lease Expense OperatingLeaseExpense	902000	USD
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	3000	USD
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2000	USD
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2000	USD
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	368000	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-4852000	USD
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	65000	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-856000	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	433000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-5708000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	434000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-5706000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	239000	USD
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	1296000	USD
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	435000	USD
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-7134000	USD
CY2021	gnss	Nondeductible Compensation Interest Expense And Other NondeductibleCompensationInterestExpenseAndOther	57000	USD
CY2020	gnss	Nondeductible Compensation Interest Expense And Other NondeductibleCompensationInterestExpenseAndOther	24000	USD
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	210000	USD
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	364000	USD
CY2021	gnss	Income Tax Reconciliation Change In Research And Development Carryover IncomeTaxReconciliationChangeInResearchAndDevelopmentCarryover	19000	USD
CY2020	gnss	Income Tax Reconciliation Change In Research And Development Carryover IncomeTaxReconciliationChangeInResearchAndDevelopmentCarryover	-219000	USD
CY2021	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	-175000	USD
CY2020	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	-7000	USD
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-117000	USD
CY2020	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-21000	USD
CY2021	gnss	Income Tax Reconciliation State Business Credit Utilization IncomeTaxReconciliationStateBusinessCreditUtilization	-234000	USD
CY2020	gnss	Income Tax Reconciliation State Business Credit Utilization IncomeTaxReconciliationStateBusinessCreditUtilization	-9000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	434000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-5706000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	20518000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	20712000	USD
CY2021Q3	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	352000	USD
CY2020Q3	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	405000	USD
CY2021Q3	gnss	Deferred Tax Liabilities Operating Rightofuse Assets DeferredTaxLiabilitiesOperatingRightofuseAssets	1222000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	11769000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	11985000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	5479000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	5686000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	538000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	317000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	8000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	15000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	2487000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	2526000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	237000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	183000	USD
CY2020Q3	gnss	Deferred Tax Liabilities Operating Rightofuse Assets DeferredTaxLiabilitiesOperatingRightofuseAssets	1334000	USD
CY2021Q3	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	2592000	USD
CY2020Q3	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	-0	USD
CY2021Q3	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	4166000	USD
CY2020Q3	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1739000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	8313000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7878000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	8039000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	11095000	USD
CY2021	us-gaap	Increase Decrease In Other Employee Related Liabilities IncreaseDecreaseInOtherEmployeeRelatedLiabilities	2625000	USD
CY2020	us-gaap	Increase Decrease In Other Employee Related Liabilities IncreaseDecreaseInOtherEmployeeRelatedLiabilities	1554000	USD
CY2021	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	219000	USD
CY2020	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	206000	USD
CY2020Q4	us-gaap	Share Price SharePrice	5.98
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	8232968
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	295000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	231270
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.485	pure
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.445	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.007	pure
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.014	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000	pure
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000	pure
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y6M
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y4M24D
CY2021Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	982000	USD
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2659305
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.56
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	295000
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	6.71
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	104125
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	2.57
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	104796
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.01
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2745384
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.02
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1541176
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.24
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	6343000	USD
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	4610000	USD
CY2021Q3	us-gaap	Share Price SharePrice	5.18
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	725000	USD
CY2021	gnss	Gross Proceeds From Stock Options Exercised GrossProceedsFromStockOptionsExercised	211000	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	2578000	USD
CY2020	gnss	Gross Proceeds From Stock Options Exercised GrossProceedsFromStockOptionsExercised	1136000	USD
CY2021	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	514000	USD
CY2020	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	1442000	USD
CY2021Q3	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	2745384
CY2021	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P3Y9M29D
CY2021Q3	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	3.02
CY2021Q3	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	1541176
CY2021Q3	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	2.24
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1424000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	980000	USD
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	104796
CY2021	gnss	Gross Proceeds From Stock Options Exercised GrossProceedsFromStockOptionsExercised	210000	USD
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	583019
CY2020	gnss	Gross Proceeds From Stock Options Exercised GrossProceedsFromStockOptionsExercised	1136000	USD
CY2021	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	228633
CY2020	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	198106
CY2021Q2	us-gaap	Share Price SharePrice	5.05
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2021Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021	us-gaap	Net Income Loss NetIncomeLoss	704000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	11874000	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.36
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.35
CY2021	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	34409478
CY2020	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	33220915
CY2021	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	1179670
CY2020	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	871413
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	35589148
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34092328
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1243692
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	893750
CY2021	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
CY2021	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	47003000	USD
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	43010000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	1084000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	6041000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1597000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	800000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	434000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-5706000	USD
CY2021Q3	us-gaap	Noncurrent Assets NoncurrentAssets	38393000	USD
CY2020Q3	us-gaap	Noncurrent Assets NoncurrentAssets	5345000	USD
CY2021Q3	us-gaap	Assets Assets	90128000	USD
CY2020Q3	us-gaap	Assets Assets	66167000	USD
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	47003000	USD
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	43010000	USD
CY2021Q3	us-gaap	Noncurrent Assets NoncurrentAssets	38393000	USD
CY2020Q3	us-gaap	Noncurrent Assets NoncurrentAssets	5345000	USD

Files In Submission

Name	View Source	Status
0001437749-21-027262-index-headers.html	Edgar Link	pending
0001437749-21-027262-index.html	Edgar Link	pending
0001437749-21-027262.txt	Edgar Link	pending
0001437749-21-027262-xbrl.zip	Edgar Link	pending
ex_308654.htm	Edgar Link	pending
ex_308655.htm	Edgar Link	pending
ex_308656.htm	Edgar Link	pending
ex_308657.htm	Edgar Link	pending
ex_308982.htm	Edgar Link	pending
ex_308983.htm	Edgar Link	pending
ex_309352.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
gnss-20210930.xsd	Edgar Link	pending
gnss-20210930_cal.xml	Edgar Link	unprocessable
gnss-20210930_def.xml	Edgar Link	unprocessable
gnss-20210930_lab.xml	Edgar Link	unprocessable
gnss-20210930_pre.xml	Edgar Link	unprocessable
gnss20210930_10k.htm	Edgar Link	pending
gnss20210930_10k_htm.xml	Edgar Link	completed
logo.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GNSS
Genasys Inc. Stock $gnss

2021 Q4 Form 10-K Financial Statement

#000143774921027262 Filed on November 23, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GNSS Genasys Inc. Stock $gnss

2021 Q4 Form 10-K Financial Statement

#000143774921027262 Filed on November 23, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GNSS
Genasys Inc. Stock $gnss